Arcadian Investment Partners
VC Fund
New York, United States
Arcadian Investment Partners (“Arcadian”) is an investment firm focused on direct investments in growing middle-market companies. Our mission is to build industry-leading middle-market companies that generate sustainable profits for the long-term.Arcadian takes majority investment positions in portfolio companies, who then benefit from having along-term operational and capital partner that supports management’s expansion strategy. Arcadian is backed by investors who have been long-term partners in past investments in the US, Europe, and Africa.
- Total investments:
- 2
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Arcadian Investment Partners invests in
Stages Arcadian Investment Partners invests in
Countries Arcadian Investment Partners invests in
Investment Focus
Industry
- Cannabis 1 (50%)
- Marketing 1 (50%)
- Compliance 1 (50%)
- Advertising 1 (50%)
- Agriculture 1 (50%)
Stage
- Series B 1 (50%)
- Series C 1 (50%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Semasio (formerly Fyllo)
|
Semasio is on a mission to power outperformance in a privacy-first world. With access to the world's most comprehensive targeting platform available, our industry-leading advertising solutions are trusted by Fortune 500 companies and emerging brands to increase reach, boost efficiency, and maximize ROI.The company was founded in 2019 and isheadquartered in Chicago, Illinois. | $40M / Series C / Nov 08, 2021 | |
PathogenDx
|
PathogenDx has developed a microarray based test specifically designed for the cannabis, botanical, food and agricultural testing markets. Our technology allows test labs to conduct between 12- 48 tests in parallel, testing up to 20 pathogens per test in less than a days’ shift. This is done at a fraction of the cost of plate counts or RealtimePCR. Our Raw Sample technology allows laboratories to bypass almost 20 steps that Real-time PCR must perform for DNA extraction and purification. PathogenDx technology bypasses the need for purification, quantitation, and normalization increasing the speed and affordability of pathogen screening. This helps our customers reduce testing time by 12 hours on the front end, and avoid spending money on sample prep kits and additional instrumentation. | $7.5M / Series B / Sep 30, 2019 |
Co-Investors
Eminence Capital LP
2 deals together
Salveo Capital
2 deals together
Altitude Investment Management
1 deal together
Ambria Capital
1 deal together
ArrowMark Partners
1 deal together
Cresco Capital Partners
1 deal together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Arcadian Investment Partners invest in?
Arcadian Investment Partners invests primarily in Cannabis, Marketing and Compliance startups, most often at Series B and Series C stage. Most of the 2 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Arcadian Investment Partners last invest?
The most recent investment recorded for Arcadian Investment Partners closed in Nov 2021. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
